Cyril Philip, Principal, Providence Ventures
Cyril Philip is a Principal at Providence Ventures (PV), where he focuses on investments in healthcare technology, tech-enabled services, and digital health. Cyril joined Providence as one of the first hires of the newly formed venture team in 2015. He currently serves as a Board Observer at Binary Fountain and Wildflower Health. Cyril also served on the Board of precision medicine company N-of-One prior to its exit. In addition, he has also participated on the deal teams for PV’s investments in InDemand Interpreting (sold), Intelligent Retinal Imaging Systems, Kyruus, Protenus, and Trilliant Health.
Prior to joining PV, Cyril was at Halyard Capital, where he focused on private equity investments in mid-stage companies in the technology, business services and healthcare sectors. Prior to Halyard, Cyril spent five years at UBS Investment Bank in the Global Healthcare group, where he worked on over 30 transactions across healthcare services/technology, life sciences and medical technology. Cyril graduated from the Tepper School of Business at Carnegie Mellon with a B.S. in Business Administration.
In his free time, Cyril enjoys volunteering, watching sports, and travelling. He sits on the Board of the Northwest Association for Global Affairs, a non-profit based in the Pacific Northwest that promotes experiential education in global affairs for college students in the region. Cyril is a transplant to Seattle from New York.